Holen Sie sich die Stockscreener-App
5.94
5.41%
-0.34
Handel nachbörslich:
5.96
0.02
+0.34%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAPR?
Forum
Prognose
Aktiensplit
Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten
Join Class Action to Recover Losses from Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky Before September 15, 2025 - The Globe and Mail
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
CAPR LAWSUIT ALERT: The Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MarketScreener
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
What is the long term forecast for Capricor Therapeutics Inc. stock2025 Trading Recap & Verified Entry Point Signals - khodrobank.com
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investor Alert: Deadline in Lawsuit on September 15, 2025 - openPR.com
Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR)Recover LossesContact Levi & Korsinsky Before September 15, 2025 - Barchart.com
Tools to assess Capricor Therapeutics Inc.’s risk profileMarket Growth Report & Growth Oriented Trade Recommendations - Newser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Morningstar
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week - Benzinga
Volatility clustering patterns for Capricor Therapeutics Inc.Market Volume Summary & Technical Pattern Alert System - Newser
Short interest data insights for Capricor Therapeutics Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser
Nuveen LLC Acquires Shares of 89,141 Capricor Therapeutics, Inc. $CAPR - Defense World
Long term hold vs stop loss in Capricor Therapeutics Inc.Weekly Profit Report & Expert Curated Trade Setup Alerts - Newser
Can Capricor Therapeutics Inc. disrupt its industryMarket Sentiment Summary & AI Powered Market Entry Ideas - khodrobank.com
Real time social sentiment graph for Capricor Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - Newser
מועד אחרון לתביעה נגד CAPR: רוזן, משרד עורכי דין מהימן ומוביל, מעודד משקיעים ב- Capricor Therapeutics, Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך - GlobeNewswire Inc.
CAPR DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CAPR - GlobeNewswire Inc.
Capricor Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
Chart based exit strategy for Capricor Therapeutics Inc.Earnings Growth Report & Free Community Consensus Stock Picks - Newser
How to forecast Capricor Therapeutics Inc. trends using time seriesJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - Morningstar
CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER - GlobeNewswire
Market Overview: Can Capricor Therapeutics Inc. expand into new marketsJuly 2025 Macro Moves & Free Community Consensus Stock Picks - khodrobank.com
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Capricor Therapeutics, Inc. $CAPR Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Will Capricor Therapeutics Inc. outperform the marketJuly 2025 Price Swings & Verified Entry Point Signals - Newser
Detecting support and resistance levels for Capricor Therapeutics Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics - TipRanks
Combining machine learning predictions for Capricor Therapeutics Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - Newser
Capricor Therapeutics Faces Challenges Despite Strong Cash Position - TipRanks
Multi factor analysis applied to Capricor Therapeutics Inc.July 2025 Catalysts & Entry and Exit Point Strategies - Newser
CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Deutsche Bank AG Has $272,000 Position in Capricor Therapeutics, Inc. $CAPR - Defense World
Vanguard Group Inc. Reduces Stock Holdings in Capricor Therapeutics, Inc. $CAPR - Defense World
Is Capricor Therapeutics Inc. forming a bottoming baseJobs Report & Fast Entry Momentum Trade Alerts - Newser
Capricor Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 15, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025CAPR - Morningstar
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - GlobeNewswire
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):